Lupin and Natco to develop generic Fosrenol in the US
This article was originally published in Scrip
Executive Summary
The Indian companies, Lupin and Natco Pharma, have formed an alliance to jointly commercialise a generic equivalent of Shire's Fosrenol (lanthanum carbonate) tablets in the US.